At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 62 enrolled
Drug / intervention
Deoxycholic Acid Injection +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of ATX-101 (Sodium Deoxycholate for Injection) Intralipomal Injections for the Treatment of Superficial Lipomas
In Brief
A Phase 2 clinical trial evaluating Deoxycholic Acid Injection and Placebo for Lipoma. Completed, enrolled 62 participants across 7 sites.
Detailed Summary
The purpose of this research is to compare the safety and effectiveness of 3 different concentrations of deoxycholic acid for injection against a placebo in the treatment of superficial lipomas.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLipoma
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2007
First PostedFeb 2008
Primary CompletionAug 2008
Study CompletionJan 2010
TodayJul 2026
First PostedFeb 6, 2008
Enrollment StartNov 1, 2007
Primary CompletionAug 1, 2008
Study CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 18.4 years ago
Interventions
Deoxycholic Acid Injectiondrug
Administered via intralipomal injection.
Placebodrug
Matching vehicle placebo administered via intralipomal injection.